NUVB (Nuvation Bio) Construction In Progress: $0.0 Mil (As of Mar. 2026)


NUVB Nuvation Bio Inc NUVB
33 GF Score
Price $5.61
! 3 Warning Signs
View Full Analysis

What is Nuvation Bio Construction In Progress?

Nuvation Bio NUVB -0.71% 33 Construction In Progress is $0.0 Mil as of Mar. 2026. GuruFocus rates NUVB with a GF Score™ of 33/100. The stock has 3 warning signs investors should review.

Nuvation Bio's quarterly construction in progress increased from Sep. 2025 ($0.0 Mil) to Dec. 2025 ($0.0 Mil) but then declined from Dec. 2025 ($0.0 Mil) to Mar. 2026 ($0.0 Mil).

Nuvation Bio's annual construction in progress stayed the same from Dec. 2023 ($0.0 Mil) to Dec. 2024 ($0.0 Mil) but then increased from Dec. 2024 ($0.0 Mil) to Dec. 2025 ($0.0 Mil).

Nuvation Bio Construction In Progress Historical Data

* Premium members only.

The historical data trend for Nuvation Bio's Construction In Progress can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Nuvation Bio Construction In Progress Chart

Nuvation Bio Annual Data
Trend Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Construction In Progress
Get a 7-Day Free Trial 0.00 0.00 0.00 0.00 0.03

Nuvation Bio Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Construction In Progress Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.03 0.00
NUVB
33GF Score
Nuvation Bio Inc NUVB
Construction In Progress is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Nuvation Bio Construction In Progress Calculation

It records the cost of construction work, which is not yet completed (typically, applied to capital budget items). A construction in progress item is not depreciated until the asset is placed in service. Normally, upon completion, a construction in progress item is reclassified, and the reclassified asset is capitalized and depreciated.

What does a Construction In Progress of $0.0 Mil mean?
Nuvation Bio (NUVB) has a Construction In Progress of $0.0 Mil as of Mar. 2026. Construction in Progress records the amount of construction work that is not complete. View historical data on Nuvation Bio and its competitors.
Is Nuvation Bio's Construction In Progress too high?
Nuvation Bio's current Construction In Progress is $0.0 Mil. Overall, Nuvation Bio has a GF Score™ of 33/100, reflecting its overall financial health beyond just this single metric.
How does Nuvation Bio's Construction In Progress compare to VRDN and STOK?
Nuvation Bio's Construction In Progress of $0.0 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Construction In Progress for a Biotechnology company?
A good Construction In Progress depends on the Biotechnology industry context. However, Construction In Progress should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Construction In Progress mean?
A high Construction In Progress can signal that a stock is expensive relative to its fundamentals. Construction in Progress records the amount of construction work that is not complete. View historical data on Nuvation Bio and its competitors. Nuvation Bio's current Construction In Progress is $0.0 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Nuvation Bio stock overvalued right now?
Nuvation Bio (NUVB) has a current Construction In Progress of $0.0 Mil. The current Construction In Progress is $0.0 Mil. Nuvation Bio's overall GF Score™ is 33/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Construction In Progress calculated?
Construction In Progress is calculated from a company's financial statements. For Nuvation Bio (NUVB), the current Construction In Progress is $0.0 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Nuvation Bio Business Description

Address 1500 Broadway, Suite 1401, New York, NY, USA, 10036
Nuvation Bio Inc is a biopharmaceutical company tackling unmet needs in oncology by developing differentiated and novel therapeutic candidates. Its product candidate, taletrectinib, is an oral, potent, central nervous system-active, selective, next-generation c-ros oncogene 1 (ROS1) inhibitor designed for the treatment of patients with ROS1+ non-small cell lung cancer (NSCLC). In addition, its clinical-stage pipeline includes oncology product candidates such as Safusidenib, NUV-1511, and NUV-868 in different stages of development. The Company generates revenue from out-licensing collaborative agreements, including product revenue, upfront license fees, royalty revenue, and research and development services revenue. The Company generates the majority of its revenue from Japan.
33GF Score

Get the complete analysis for NUVB

Construction In Progress is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$5.61
Price